L. Johansen

Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder

H. Blomgren, I. Näslund, P. Esposti, 1987, Cancer Immunology, Immunotherapy.

Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma.

H. Blomgren, I. Näslund, P. Esposti, 1990, Acta oncologica.

Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial

A. Waage, S. Evensen, I. Talstad, 1987, European journal of haematology. Supplementum.

Abstract CT210: A Phase I, open-label, multicenter, dose escalation study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral injection alone and in combination with immune checkpoint blockade

A. Jimeno, J. Frederick, T. Zaks, 2019, Clinical Trials.

767 Safety and preliminary efficacy of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ for intratumoral (ITu) injection, and durvalumab (IV) in TNBC, HNSCC, and melanoma

A. Jimeno, J. Frederick, S. Kummar, 2022, Regular and Young Investigator Award Abstracts.